期刊文献+

双嘧达莫辅助丙种球蛋白及阿司匹林治疗川崎病对患儿抗血小板聚集因子及疗效影响研究 被引量:52

Clinical analysis of different doses of gamma globulin intravenous injection combined with Aspirin in children with Kawasaki disease
下载PDF
导出
摘要 目的:探讨双嘧达莫辅助丙种球蛋白(IVIG)及阿司匹林对川崎病(KD)患儿抗血小板聚集因子及疗效的影响。方法:将60例KD患儿随机均分为两组,对照组仅采用静脉滴注IVIG及口服阿司匹林进行治疗;观察组患儿在此基础上加服双嘧达莫进行治疗。记录两组患儿住院时间及临床症状消退时间;对比两组患儿治疗前后抗血小板聚集相关影响因子[血小板计数(PLT)、白细胞计数(WBC)、红细胞沉降率(ESR)]水平变化情况;比较两组患儿出现冠状动脉损伤状况及治疗有效率。结果:与对照组相比,观察组患儿住院时间、临床症状消退时间均明显缩短,冠状动脉损伤发生人数明显减少,治疗总有效率明显提高(P<0.05)。经治疗,两组患儿抗血小板聚集相关因子PLT、WBC、ESR水平均明显下降;且观察组患儿上述因子水平均明显优于对照组(P<0.05)。结论:双嘧达莫辅助IVIG及阿司匹林治疗KD可有效抑制血小板聚集,改善患儿免疫功能,缓解临床症状,降低冠状动脉损伤发生率,提高治疗效率。 Objective:To analyze the clinical effect of different doses of gamma globulin(IVIG)combined with Aspirin in the treatment of childhood Kawasaki disease(KD).Methods:45 patiences with KD were divided into three groups randomly.The cases of group A were treated with 400 mg/(kg·d)IVIG for 5 days,and group B received single dose of 1 g/(kg·d)for 2 days,and group C received single-dose of 2 g/(kg·d).The children of three groups were treated with aspirin.The hospitalization time and clinical symptoms subsided time was recorded in detail of all children,the levers of platelet count(PLT),white blood cell count(WBC),erythrocyte sedimentation rate(ESR)and C-reactive protein(CRP)four inflammatory changes were recorded before and after treatment of tree groups;and the coronary artery injury and the treatment of efficiency were recorded with each group.Results:Compared with group A,the hospitalization time and clinical symptoms subsided time of group B and group C were both significantly shortened,and the four inflammatory indexes were significantly better than group A(P <0.05),but there was no significant difference betweeen group B and group C in the hospitalization time,clinical symptoms subsided time and the four inflammatory indexes(P>0.05).The incidence rate of coronary artery injury in group C was significantly lower than that in group A(P<0.05),and there was no significant difference of the coronary artery injury incidence rate between group B and group A,group B and group C(P>0.05).There was no significant difference in the total effective rate between group B and group C(P >0.05),but there was a significant difference between group B and group A,group C and group A(P<0.05).Conclusion:High-dose IVIG combined with Aspirin in children with Kawasaki disease treatment has significant effect,can effectively reduce hospitalization and clinical symptoms subsided time,inhibit the release of inflammatory cytokines,reduce the incidence of coronary artery injury.
作者 邹娜
出处 《陕西医学杂志》 CAS 2018年第1期102-104,共3页 Shaanxi Medical Journal
基金 国家自然科学基金资助项目(81303147)
关键词 黏膜皮肤淋巴结综合征/药物疗法 丙种球蛋白类/治疗应用 阿司匹林/治疗应用 Mucocutaneous lymph node syndrome/drug therapy Gamma globulin/therapeutic use Aspirin/therapeutic use
  • 相关文献

参考文献11

二级参考文献96

  • 1薛清,徐志云,韩林,张冠鑫,陆方林,唐昊,徐激斌.川崎病伴发冠状动脉损害的外科治疗[J].中华临床医师杂志(电子版),2011,5(21):6236-6238. 被引量:2
  • 2张乾忠.不典型川崎病的临床表现和诊断[J].中国实用儿科杂志,2006,21(10):728-730. 被引量:118
  • 3舒琼璋,杨武英.川崎病血液流变学变化与冠状动脉损害的关系[J].实用医技杂志,2007,14(6):749-750. 被引量:2
  • 4金虹 梁翊常 等.正常儿童冠状动脉超声心动图研究[J].中华儿科杂志,1988,26:257-259.
  • 5胡亚美,江载芳,主编.诸福棠实用儿科学.7版[M].北京:人民卫生出版社,2002,1167-1175.
  • 6李白普.小儿后天性心脏病学[M].济南:山东科学技术出版社,2003.148.
  • 7Dajani AS, Taubert KA, Gerber MA, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation, 1993, 87: 1776- 1780.
  • 8Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Bheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 2004, 110 : 2747-2771.
  • 9Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int, 2005, 47:232-234.
  • 10Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics, 2004. 114: 1708-1733.

共引文献248

同被引文献317

引证文献52

二级引证文献184

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部